In a previous case–control study, missense mutations in PLCG1 were reported to participate in the pathogenesis of cutaneous T-cell lymphomas by enhancing downstream signaling towards nuclear factor of activated T-cell activation. The gene discussed is PLCG1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.